Apotex Corp. recalls Guanfacine Extended-Release Tablets 2 mg,100-count bottles,
See all recalls from Apotex Corp. →Recalled Product
Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-3928-1, UPC 3 60505 39281 0
Hazard / Issue
Cross Contamination with Other Product: Product is being recalled due to Trace Amounts of Quetiapine Fumarate
Issued by
FDA
Distribution: Nationwide (United States)
Lot/Code Info: Lot #: RX1662, RX1663, RX1664 Exp. 11/2022
✅ What Should You Do?
- 1Stop taking this medication and contact your doctor or pharmacist immediately.
- 2Do NOT flush medications down the drain — use an FDA-approved drug take-back program.
- 3Check the lot number on your bottle or packaging against the recalled lots listed above.
- 4Report adverse events to FDA MedWatch or call 1-800-FDA-1088.
Looking for a safe alternative?
Search Amazon for Guanfacine Extended-Release Tablets 2 →If you were harmed by this recalled product, Top Class Actions lists active class action lawsuits and settlements that may apply to you.
Get the next US recall alert before it hits the news.
Free. Weekly digest or instant alerts. Unsubscribe anytime.
CAN-SPAM compliant · No spam · Unsubscribe anytime